Health-ITNews

HealthPlix EMR launches interactive ‘Drug-Drug Interaction’ feature to assist doctors

The novel feature is available for doctors across 16 specialities on HealthPlix platform

HealthPlix Technologies announced the release of its new feature – ‘Drug to Drug Interaction’ (DDI). DDI is an intuitive feature that sits on the HealthPlix EMR to help doctors recall molecule-to-molecule interactions at the time of care. 

THIS CAN BE YOUR ADVERTISEMENT

The feature is live on the HealthPlix platform and optimised for prompting these interactions while the doctor prescribes the medicines to their patients. Currently, doctors rely on support from external websites/platforms to understand these interactions which add to the total time taken to write prescriptions. With HealthPlix, doctors stand to benefit from the information being made available to them within the HealthPlix EMR.  

“Our vision is to build assistive technologies for doctors so that they can help improve patient health outcomes. DDI launch is an important step towards that vision. HealthPlix’s interactive cloud-based EMR platform allows us to nudge the doctor with key medical information at the point of care. Proud of our product innovation team,” says Chaitanya Raju, Chief of AI, HealthPlix Technologies.

Commenting on the feature release, Subhadeep Mondal, Vice President – Products at HealthPlix Technologies said, “HealthPlix is known to strengthen the health-tech ecosystem and improve healthcare delivery by making it more precise for every patient the doctor treats. By suggesting interactions between incompatible drugs, this new DDI feature will assist them. With a robust global interaction library in place, we intend to partner with organisations who specialise in drug-drug interactions, as well as citing research publications to back up our claims.”

A well-defined reference interactions library can assist doctors in identifying potentially unsafe combinations of medications. Furthermore, the company plans to ramp up its database/information by integrating with global third-party providers who specialize in drug-to-drug interactions. HealthPlix expects its reference interaction library to grow from 4L to 10L by March 2023. 

Support us in our endeavor to bring you Advertisement free content.
Choose your options to donate or subscribe.

Tags

Related Articles

Back to top button
Close
Close